| 臺大學術典藏 |
2022-09-19T03:16:56Z |
Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome
|
Wang C.-Y.; Lin Z.-F.; Lee C.-M.; Tsai Y.-W.; Huang T.-Y.; Shen L.-J.; FEI-YUAN HSIAO |
| 義守大學 |
2009-12 |
Concomitant Use of Clopidogrel and Proton Pump Inhibitors or Cimetidine After Acute Myocardial Infarction Would Increase the Risk of Re-Infarction
|
Sophie Sheng-Wen Wang;Shang-Shyue Tsai;Po-Chao Hsu;Chun-Yuh Yang;Deng-Chyang Wu |
| 高雄醫學大學 |
2009 |
Concomitant Use of Clopidogrel and Proton Pump Inhibitors or Cimetidine Following Acute Myocardial Infarction Would Increase the risk of Re-Infarction
|
陳藝祐;王聖雯;蔡世盟;許栢超;楊俊毓;吳登強;林宗憲;賴文德;許勝雄 |
| 高雄醫學大學 |
2009 |
CONCOMITANT USE OF CLOPIDOGREL AND PROTON PUMP INHIBITORS, OR CIMETIDINE, FOLLOWING ACUTE MYOCARDIAL INFARCTION WOULD INCREASE THE RISK OF RE-INFARCTION
|
王聖雯;許栢超;蔡尚學;楊俊毓;吳登強 |
| 國立臺灣大學 |
2014 |
Concomitant Use of Clopidogrel with Calcium Channel Blockers and Cardiovascular Outcomes in Patients Received Percutaneous Coronary Intervention
|
Wang, Chen-Yu; Hsiao, Fei-Yuan; Lin, Zhen-Fang; Shen, Li-Jiuan; 蕭斐元; 沈麗娟 |
| 臺大學術典藏 |
2018-09-10T18:07:46Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien, Feng-Ming and Hou, Hsin-An and Tang, Jih-Luh and Kuo, Yuan-Yeh and Chen, Chien-Yuan and Tsai, Cheng-Hong and Yao, Ming and Lin, Chien-Ting and Li, Chi-Cheng and Huang, Shang-Yi and Ko, Bor-Sheng and Hsu, Szu-Chun and Wu, Shang-Ju and Liu, Jia?Hau and Chou, Sheng?Chieh and Tsay, Woei and Tseng, Mei-Hsuan and Liu, Ming-Chih and Liu, Chia-wen and Lin, Liang-In and Chou, Wen-Chien and Tien, Hwei-Fang; Cheng-Hong Tsai |
| 臺大學術典藏 |
2020-06-16T07:53:23Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chen C.-Y.;Tsai C.-H.;Yao M.;Lin C.-T.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Liu J.-H.;Chou S.-C.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Chou W.-C.;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
TIEN FENG-MING; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; CHENG-HONG TSAI; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Li C.-C.; Huang S.-Y.; Lin C.-T.; Yao M.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-05T00:56:25Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; MING YAO; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-12T12:53:48Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:16Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chen C.-Y.;Tsai C.-H.;Yao M.;Lin C.-T.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Liu J.-H.;Chou S.-C.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Lin L.-I.;Wen-Chien Chou;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; WEN-CHIEN CHOU; Tien H.-F. |
| 臺大學術典藏 |
2021-07-22T03:35:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; LIU JIA-HAU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:17Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T02:30:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Lin C.-T.; Li C.-C.; Yao M.; Chen C.-Y.; Tsai C.-H.; Kuo Y.-Y.; Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; SHENG-CHIEH CHOU; Tsay W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:12Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:04Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-18T08:38:05Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chieh-Chang Chen; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
